They also found that treatment with Blautia and acetate stimulated the antineoplastic responses of CD8+ T cells and reversed disease progression in female mice, concluding that Blautia-derived acetate may be the key to modulating immune responses to breast cancer. This evidence concerns the gene CD8A and breast cancer.